|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.00 ARS | +2.53% |
|
-1.22% | -32.64% |
| Market Cap | 689.95Cr 46.24L 40.46L 37.29L 34.56L 65.61L 44Cr 66.67L 4.47Cr 1.74Cr 22Cr 1.74Cr 1.7Cr 75Cr | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 763.72Cr 51.18L 44.79L 41.28L 38.26L 72.63L 49Cr 73.8L 4.95Cr 1.92Cr 24Cr 1.92Cr 1.88Cr 83Cr | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.53% | ||
| 1 week | -1.22% | ||
| Current month | -0.61% | ||
| 1 month | +0.31% | ||
| 3 months | -14.96% | ||
| 6 months | -26.70% | ||
| Current year | -32.64% |
| 1 week | 155 | 165.5 | |
| 1 month | 155 | 171.5 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4.2 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.53% | -1.22% | +15.10% | +636.36% | 46.26L | ||
| +1.20% | +5.52% | -51.72% | -54.63% | 3.16TCr | ||
| -1.81% | +0.22% | +70.46% | +145.67% | 1.26TCr | ||
| -4.51% | +1.26% | -16.75% | +0.25% | 382.12Cr | ||
| +0.46% | -1.80% | -1.66% | +30.60% | 310.89Cr | ||
| -0.86% | +6.58% | +56.51% | +32.81% | 204.9Cr | ||
| -0.17% | +3.25% | -27.80% | +18.24% | 165.53Cr | ||
| -3.25% | +5.89% | +11.20% | +131.71% | 138.45Cr | ||
| -1.63% | +5.85% | -20.23% | -9.49% | 106.86Cr | ||
| +1.26% | +2.26% | -3.07% | -17.33% | 95Cr | ||
| Average | -0.65% | +1.54% | +3.20% | +91.42% | 582.12Cr | |
| Weighted average by Cap. | -0.17% | +1.97% | -13.04% | +7.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827.49Cr 55.45L 48.53L 44.72L 41.45L 78.69L 53Cr 79.96L 5.36Cr 2.09Cr 26Cr 2.08Cr 2.04Cr 90Cr | 640.36Cr 42.91L 37.55L 34.61L 32.08L 60.9L 41Cr 61.88L 4.15Cr 1.61Cr 20Cr 1.61Cr 1.58Cr 69Cr |
| Net income | -141.73Cr -9L -8L -8L -7L -13.48L -9.01Cr -13.7L -91.85L -35.72L -4.45Cr -35.66L -34.89L -15Cr | -459.77Cr -30.81L -26.96L -24.85L -23.03L -43.72L -29Cr -44.43L -2.98Cr -1.16Cr -14Cr -1.16Cr -1.13Cr -50Cr |
| Net Debt | 86Cr 6L 5L 5L 4L 8L 5.49Cr 8L 55.94L 21.75L 2.71Cr 21.72L 21.25L 9.37Cr | 74Cr 5L 4L 4L 4L 7L 4.69Cr 7L 47.81L 18.59L 2.32Cr 18.56L 18.16L 8Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | ARS 162.00 | +2.53% | 14,507 |
| 03/26/03 | ARS 158.00 | -3.07% | 3,769 |
| 02/26/02 | ARS 163.00 | 0.00% | 9,583 |
| 01/26/01 | ARS 163.00 | 0.00% | 11,988 |
| 30/26/30 | ARS 163.00 | -0.61% | 17,133 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















